# BioGenerator Ventures

> BioGenerator Ventures is a VC fund in St Louis backing Medical and Biotechnology. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: St Louis, United States
- Total investments: 8
- Last investment: Jul 2026
- Lead investor: 25%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/biogeneratorventures
- Website: https://www.biogeneratorventures.com

BioGenerator Ventures is a VC fund in St Louis focused on Medical and Biotechnology. BioGenerator Ventures creates, builds, and invests in companies that are solving problems in human health and agriculture.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 38% |
| Biotechnology | 3 | 38% |
| Farming | 2 | 25% |
| Agriculture | 2 | 25% |
| Health Care | 2 | 25% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 50% |
| Pre-Seed | 1 | 13% |
| Series A | 1 | 13% |
| Series B | 1 | 13% |
| Series C | 1 | 13% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Wugen | Wugen is developing off-the-shelf cellular therapies for cancer. Our NK cell therapy products originate from healthy donors and are further manipulated in order to enhance their function to eliminate cancer cells. Our NK cell and CAR-T immuno-oncology therapies address the needs of patients with solid tumors, acute myeloid leukemia (AML) and T-cellmalignancies. | $35M | Series C | Jul 08, 2026 |  |
| Pairidex | Pairidex Using cutting-edge technology to establish itself as the sole supplier of thorough blood cancer detection |  | Seed | Feb 23, 2026 |  |
| Plastomics | Plastomics is a biotechnology startup that focuses in developing the next generation of crops by using chloroplast genetic engineering. Its technology platform is applicable to different crops and traits. Plastomics provides solutions for the many current industry challenges.The company was founded in 2016 and headquartered in St. Louis,Missouri. | $5.8M | Series B | Oct 15, 2025 |  |
| Aegis Digital Health | Aegis Digital Health delivers solutions in virtual care and remote patient monitoring to healthcare providers. | $1M | Seed | Sep 11, 2025 |  |
| Edison Agrosciences | Edison Agrosciences is an agricultural biotechnology company dedicated to developing and commercializing innovative solutions for the production of plant-based industrial materials, with a primary focus on the development of alternative rubber crops. They are engineering yield improvements and the novel production of industrial materials insuitable plant systems. Edison has an emerging IP portfolio covering multiple technical strategies and they are developing strategic partnerships to mitigate the risk of pilot scale crop and product validation. Edison’s strong leadership team has a track record of success in industry. | $600K | Seed | Jul 25, 2024 |  |
| Maximum Fidelity Surgical Simulations | Maximum Fidelity Surgical Simulations manufactures medical, surgical, ophthalmic, and veterinary instruments and apparatus. It prepares medical personnel for military trauma, test biomedical devices, and provides hyper-realistic medical education using a lifelike patient and without endangering human life. | $2.3M | Seed | Jul 09, 2024 |  |
| Solis Agrosciences | Solis Agrosciences provides R&D crop development services to Agtech companies. Founded in 2021, Solis Agrosciences is a plant science services company on a mission to accelerate the pace of scientific discovery and commercialization. | $200K | Series A | May 11, 2023 |  |
| Solis Agrosciences | Solis Agrosciences provides R&D crop development services to Agtech companies. Founded in 2021, Solis Agrosciences is a plant science services company on a mission to accelerate the pace of scientific discovery and commercialization. | $275K | Pre-Seed | Dec 15, 2021 |  |

8 of 8 investments shown.

## Co-investors
- [Missouri Technology Corporation](https://shizune.co/investors/profile/missouri-technology-corporation) — VC Fund, 6 deals together
- [St. Louis Arch Angels](https://shizune.co/investors/profile/st-louis-arch-angels) — VC Fund, 2 deals together
- [Arch Grants](https://shizune.co/investors/profile/arch-grants) — VC Fund, 1 deal together
- [CGSTL Group](https://shizune.co/investors/profile/cgstl-group) — VC Fund, 1 deal together
- [CIG Spectrum Capital](https://shizune.co/investors/profile/cig-spectrum) — VC Fund, 1 deal together
- [Crisp & Company](https://shizune.co/investors/profile/crisp-company) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does BioGenerator Ventures invest in?

BioGenerator Ventures invests primarily in Medical, Biotechnology and Farming startups, most often at Seed and Pre-Seed stage. Most of the 8 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did BioGenerator Ventures last invest?

The most recent investment recorded for BioGenerator Ventures closed in Jul 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co